0.20Open0.10Pre Close1.07K Volume2.65K Open Interest77.00Strike Price24.14KTurnover171.74%IV0.29%PremiumDec 13, 2024Expiry Date0.00Intrinsic Value100Multiplier0DDays to Expiry0.03Extrinsic Value100Contract SizeAmericanOptions Type-0.2137Delta1.1811Gamma2573.00Leverage Ratio-28.6965Theta0.0000Rho-549.91Eff Leverage0.0004Vega
DexCom Stock Discussion
Revenue came in at $994.2 million, topping the forecast of $990.71 million and showing growth from last year's $975 million.
The company announced that Teri Lawver, EVP and Chief Commercial Officer, will retire by year-end, with CEO Kevin Sayer temporarily leading the commercial team.
DexCom reaffirmed its 2024 sales outl...
No comment yet